Wealthedge Investment Advisors’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
IC
MCM
MHP
FCM
Wealthedge Investment Advisors's STIM Position: Q1 2025 in Review
Wealthedge Investment Advisors sold out of Neuronetics (STIM) in Q1 2025, closing a stake of 35,199 shares — an estimated $56.7K sold.
Wealthedge Investment Advisors first reported a position in STIM in Q4 2024 and held it in 1 quarter. The position peaked at $56.7K in Q4 2024. 102 funds tracked by Wall St. Rank hold STIM as of Q1 2025.
- Wealthedge Investment Advisors reported no remaining Neuronetics position as of Q1 2025 after selling out during the quarter.
- Wealthedge Investment Advisors sold 35,199 Neuronetics shares in Q1 2025, an estimated $56.7K.
- Wealthedge Investment Advisors first reported a position in Neuronetics in Q4 2024 and held it in 1 quarter.
- Wealthedge Investment Advisors's Neuronetics position peaked at $56.7K in Q4 2024.
- 102 funds tracked by Wall St. Rank held Neuronetics as of Q1 2025.
Based on Wealthedge Investment Advisors's 13F filing for Q1 2025, filed 13 May 2025.